FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8101211000001101: Betahistine 16mg tablets (Zentiva Pharma UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1512351000001116 Betahistine 16mg tablets (Zentiva Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1512361000001118 Betahistine 16mg tablets (Zentiva Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Is a Product containing precisely betahistine 16 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Is a Betahistine 16mg tablets true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Is a Betahistine 16mg tablets false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has active ingredient Betahistine dihydrochloride false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has active ingredient Betahistine false Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient Betahistine dihydrochloride true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) 84 tablet 7 x 12 tablets Is pack of False Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Inferred relationship Existential restriction modifier
Betahistine 16mg tablets (Zentiva Pharma UK Ltd) 84 tablet 7 x 12 tablets Has AMP True Betahistine 16mg tablets (Zentiva Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start